Literature DB >> 11513778

Incidence of cancer of the pancreas, extrahepatic bile duct and ampulla of Vater in the United States, before and after the introduction of laparoscopic cholecystectomy.

D R Urbach1, L L Swanstrom, Y S Khajanchee, P D Hansen.   

Abstract

BACKGROUND: Some epidemiologic studies have identified cholecystectomy as a risk factor for pancreatic and biliary cancer.
METHODS: We compared the incidence of cancers of the pancreas, extrahepatic bile duct and ampulla of Vater before and after the widespread adoption of laparoscopic cholecystectomy in the United States in 1991, when the use of cholecystectomy increased dramatically.
RESULTS: Compared with 1980 to 1991, there was no increase in the incidence of cancer of the pancreas (adjusted incidence rate ratio [IRR] 0.97, 95% confidence interval [CI] 0.94 to 0.99) or extrahepatic bile duct (IRR 0.80, 95% CI 0.74 to 0.87) during 1992 to 1996. There was a small increase in the incidence of ampullary cancer (IRR 1.14, 95% CI 1.03 to 1.26).
CONCLUSIONS: We did not find clear evidence of a short-term increase in the incidence of cancers of the pancreas, bile duct, and ampulla of Vater, that was attributable to the increased use of cholecystectomy.

Entities:  

Mesh:

Year:  2001        PMID: 11513778     DOI: 10.1016/s0002-9610(01)00631-6

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  10 in total

Review 1.  Cholecystectomy and the risk of alimentary tract cancers: a systematic review.

Authors:  Maria Coats; Sami M Shimi
Journal:  World J Gastroenterol       Date:  2015-03-28       Impact factor: 5.742

2.  Increased cholecystectomy rate in the laparoscopic era: a study of the potential causative factors.

Authors:  Peter Sipos; Osama Damrah
Journal:  Surg Endosc       Date:  2007-03-13       Impact factor: 4.584

3.  Trends in incidence and management of cancer of the ampulla of Vater.

Authors:  Florian Rostain; Samia Hamza; Antoine Drouillard; Jean Faivre; Anne-Marie Bouvier; Côme Lepage
Journal:  World J Gastroenterol       Date:  2014-08-07       Impact factor: 5.742

4.  Cholecystectomy and the risk of colorectal adenomas.

Authors:  Lisa C Vinikoor; Joseph A Galanko; Robert S Sandler
Journal:  Dig Dis Sci       Date:  2007-08-21       Impact factor: 3.199

5.  Gallstones and the Risk of Gallbladder Cancer Mortality: A Cohort Study.

Authors:  Seungho Ryu; Yoosoo Chang; Kyung Eun Yun; Hyun-Suk Jung; Jun Ho Shin; Hocheol Shin
Journal:  Am J Gastroenterol       Date:  2016-08-30       Impact factor: 10.864

6.  Risk of hepato-biliary cancer after cholecystectomy: a nationwide cohort study.

Authors:  Wei-Yu Kao; Chian-Yaw Hwang; Chien-Wei Su; Yun-Ting Chang; Jiing-Chyuan Luo; Ming-Chih Hou; Han-Chieh Lin; Fa-Yauh Lee; Jaw-Ching Wu
Journal:  J Gastrointest Surg       Date:  2012-11-27       Impact factor: 3.452

7.  Gallstones and cholecystectomy in relation to risk of intra- and extrahepatic cholangiocarcinoma.

Authors:  H Nordenstedt; F Mattsson; H El-Serag; J Lagergren
Journal:  Br J Cancer       Date:  2012-01-12       Impact factor: 7.640

8.  Systematic review and meta-analysis: cholecystectomy and the risk of cholangiocarcinoma.

Authors:  Jianping Xiong; Yaqin Wang; Hanchun Huang; Jin Bian; Anqiang Wang; Junyu Long; Ying Zheng; Xinting Sang; Yiyao Xu; Xin Lu; Haitao Zhao
Journal:  Oncotarget       Date:  2017-07-26

9.  Risk factors for the occurrence of ampullary tumors: A case-control study.

Authors:  Piera Zaccari; Livia Archibugi; Giulio Belfiori; Enrico Nista; Giuseppe dell'Anna; Stefano Crippa; Tommaso Schepis; Matteo Tacelli; Francesca Aleotti; Maria Chiara Petrone; Alberto Mariani; Guido Costamagna; Antonio Gasbarrini; Alberto Larghi; Massimo Falconi; Paolo Giorgio Arcidiacono; Gabriele Capurso
Journal:  United European Gastroenterol J       Date:  2022-07-27       Impact factor: 6.866

10.  Cholecystectomy, gallstones, tonsillectomy, and pancreatic cancer risk: a population-based case-control study in Minnesota.

Authors:  J Zhang; A E Prizment; I B Dhakal; K E Anderson
Journal:  Br J Cancer       Date:  2014-03-25       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.